生命科学资讯

Ono’s Deciphera drops early-stage solid tumor drug for strategic reasons

Teva bags $400M deal with Blackstone to fund Sanofi-partnered IBD drug

Picton Mahoney Asset Management Takes $17.01 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat

UCB boards T cell engager train in $60M upfront deal with Antengene

Blackstone to support Teva on Sanofi-partnered TL1A with $400M

Sanofi strikes $1.5B global licensing deal for Sino Biopharm's first-in-class JAK/ROCK asset

Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com

Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition

Ancient photoreceptor shapes behavioural responses

News | Biotech giant recommits to major Wisconsin hub despite cuts across US office portfolio - CoStar

10x Genomics at TD Cowen Conference: Navigating Challenges with Strategic Initiatives - Investing.com India

Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant

Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Old school healthcare is warming up to tech

[Form 4] AGILENT TECHNOLOGIES, INC. Insider Trading Activity - Stock Titan

Prime Medicine reverses course to seek FDA approval of shelved therapy

After years of dispute with FDA, Vanda will get a public hearing for jet lag drug

Kyowa Kirin ends OX40 trials after Amgen balked, safety concern

New cancer cases prompt Kyowa to discontinue late-stage autoimmune disease program